Evidence map›Paper›PMID 37103090›Full record

ArticleIn vivo (Athens, Greece)

The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease.

Takayuki Manabe, Kuninori Iwayama, Masayuki Chuma, Yoshikazu Tasaki, Seiji Matsumoto

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Takayuki Manabe *Clinical Research Support Center, Asahikawa Medical University Hospital, Asahikawa, Japan; tmanabe@asahikawa-med.ac.jp.
Kuninori Iwayama *Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Masayuki ChumaDepartment of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Yoshikazu TasakiClinical Research Support Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
Seiji MatsumotoClinical Research Support Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
Asahikawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimInterstitial lung disease (ILD) is a serious adverse event (AE) associated with the use of immune checkpoint inhibitors (ICIs). However, the risk factors for developing ICI-related ILD remain poorly understood. Therefore, this study investigated the effect of concomitant analgesics on developing ICI-related ILD using the Japanese Adverse Drug Event Report (JADER) database. PATIENTS AND

methodsAll the reported AE data were downloaded from the Pharmaceuticals and Medical Devices Agency website, and the JADER data between January 2014 and March 2021 were analysed. The relationship between ICI-related ILD and concomitant use of analgesics was assessed using reporting odds ratio (ROR) and 95% confidence interval. We investigated whether the effect of developing ILD varied according to the type of analgesics used during ICI treatment.

resultsPositive signals for ICI-related ILD development were detected for the concomitant use of the narcotic analgesics codeine, fentanyl and oxycodone, but not with morphine. In contrast, there were no positive signals for the concomitant use of the non-narcotic analgesics celecoxib, acetaminophen, loxoprofen and tramadol. An increased ROR for ICI-related ILD in cases with concomitant use of narcotic analgesics was observed in a multivariate logistic analysis adjusted by sex and age.

conclusionThese results suggest that the concomitant use of narcotic analgesics is involved in the development of ICI-related ILD.

Indexed as

Drug-Related Side Effects and Adverse ReactionsLung Diseases, InterstitialAnalgesicsHumansImmune Checkpoint InhibitorsMorphineRetrospective StudiesRisk FactorsAnalgesicsImmune Checkpoint InhibitorsMorphineadverse eventsImmune checkpoint inhibitorsinterstitial lung diseaseJapanese Adverse Drug Event Report databasenarcotic analgesicsreporting odds ratio

Identifiers

PMID37103090
PMCPMC10188036
OpenAlexW4367174232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.